Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema

Eri Ito, Yoshinao Muro, Akitaka Shibata, Kazumitsu Sugiura, Masashi Akiyama

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Hydroxyurea (HU) is a chemotherapeutic agent used for the treatment of myeloproliferative disorders such as chronic myeloid leukemia, polycythemia vera, and essential thrombocytosis. We describe a 69-year-old man who had essential thrombocytosis and developed amyopathic dermatomyositis after long-term HU therapy. He presented with Gottron papules and heliotrope erythema. The former has been described in all cases of HU-induced dermatomyositis; the latter has been seen in a few cases of that disorder.

Original languageEnglish
JournalDermatology Online Journal
Issue number8
Publication statusPublished - 2014
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Dermatology


Dive into the research topics of 'Hydroxyurea-induced amyopathic dermatomyositis presenting with heliotrope erythema'. Together they form a unique fingerprint.

Cite this